# Christopher Skowronek

> Christopher Skowronek is the Chief Executive Officer of NuvoAir Medical, a Boston-based, virtual-first specialty care company built around the people most healthcare leaves waiting: patients with complex heart and lung conditions. He climbed into the top job after running growth and business for the company, and after two decades shaping sales and operations strategy across payers, providers and care-management platforms like Lumeris and Bamboo Health. His operating creed, borrowed from NuvoAir's own motto, is blunt: no one left behind. In 2026 he steered the company through the sale of its clinical-trials arm to Strados Labs so NuvoAir could do one thing without distraction - deliver cardiopulmonary care to patients across the country.

- **Role:** Chief Executive Officer at NuvoAir Medical
- **Organizations:** NuvoAir Medical, Bamboo Health, Lumeris, North Carolina Healthcare Association
- **Nationality:** American
- **Education:** AB, Economics, Harvard University, Master's, Healthcare Administration, University of North Carolina at Chapel Hill
- **Known for:** Rose from a growth/business leadership role to Chief Executive Officer of NuvoAir Medical, More than 20 years shaping sales and operations strategy across the healthcare ecosystem, Helped expand NuvoAir's virtual-first cardiopulmonary care across two continents

## Career timeline

- **2002** — Earns AB in Economics from Harvard University
- **2013-2014** — Vice President, Strategic Initiatives at the North Carolina Healthcare Association
- **2013-2017** — Executive Director, Center for Affordable Health Care at the North Carolina Healthcare Association
- **2017** — Completes Master's in Healthcare Administration at UNC Chapel Hill
- **2017-2020** — Holds market and operations leadership roles at Lumeris, including General Manager of Population Health Services and Market Medicare Advantage Operations Head
- **2020-2022** — Vice President of Payer Strategy and later Partnerships VP, Corporate Strategy at Bamboo Health
- **2023** — Joins NuvoAir, leading growth and business as Chief Growth Officer / Chief Business Officer
- **2024** — NuvoAir announces partnership with Cary Medical Management to bring cardiopulmonary care to rural North Carolina
- **2025** — Promoted to Chief Executive Officer of NuvoAir Medical
- **2026** — Leads sale of NuvoAir's clinical-trials business to Strados Labs, refocusing the company on patient care

## Achievements

- Rose from a growth/business leadership role to Chief Executive Officer of NuvoAir Medical
- More than 20 years shaping sales and operations strategy across the healthcare ecosystem
- Helped expand NuvoAir's virtual-first cardiopulmonary care across two continents
- Drove the 2024 partnership bringing specialty heart and lung care to rural North Carolina
- Negotiated the 2026 divestiture of NuvoAir's clinical-trials arm to Strados Labs to sharpen the company's focus on care delivery

## Latest updates

- **2026-04** — Strados Labs acquired NuvoAir's clinical-trials business; Skowronek said the move lets NuvoAir Medical focus solely on patient care nationwide.
- **2025-01** — Identified publicly as Chief Executive Officer of NuvoAir, after leading the company's growth and business functions.

## Links

- Website: https://nuvoair.com
- LinkedIn: http://www.linkedin.com/in/christopher-skowronek-7425a132

---

Profile page: https://yespress.io/christopher-skowronek
Published by YesPress — https://yespress.io
Last updated: 2026-06-14